Innovative Technology Advanced Oncotherapy's LIGHT system, developed with CERN technology, represents a groundbreaking, cost-effective proton radiotherapy solution that is designed to be accessible in major city centers worldwide, presenting a unique selling proposition for cancer treatment facilities.

Strategic Funding The company has successfully raised significant funding rounds, including over 10 million USD since 2019, demonstrating strong investor confidence and providing resources to accelerate manufacturing and deployment of its LIGHT technology.

Market Opportunity With a focus on making proton therapy affordable and accessible, there is a clear opportunity to target cancer treatment centers, hospitals, and healthcare providers seeking innovative, scalable solutions to expand their oncology services.

Growth Potential Despite current revenue under 1 million USD, ongoing development and recent funding indicate potential for market entry and expansion, especially as funding supports advancements in technology and operational readiness.

Competitive Differentiation By leveraging the unique CERN-developed technology and emphasizing affordability and city-center accessibility, Advanced Oncotherapy can differentiate itself from traditional heavyweights like IBA and Coherent Oncology, appealing to forward-thinking health systems.